NeoGenomics Laboratories

NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. We work every day to achieve our common purpose of saving lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. Our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor FISH testing with the largest menu of technical-only services available; 10-color flow cytometry; IHC supported by an extensive antibody library; and nearly 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. Our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out FISH, flow cytometry, and/or IHC. NeoGenomics’ extremely fast test development cycle means we are highly responsive to therapy development and guideline changes, and test design always involves a balance of convention and innovation. We support clients in many cancer-related market segments, to include: hospital and private pathology laboratories, office-based oncologists, CRO / Biopharmaceutical development organizations, academic institutions / teaching hospitals, and several more.
Company Growth (employees)
Type
Public
HQ
Fort Myers, US
Founded
2002
Size (employees)
938 (est)
NeoGenomics Laboratories was founded in 2002 and is headquartered in Fort Myers, US

NeoGenomics Laboratories Office Locations

NeoGenomics Laboratories has offices in Fort Myers, Nashville, Tampa, Irvine and in 1 other location
Fort Myers, US (HQ)
9 12701 Commonwealth Dr
Fresno, US
400 30 River Park Pl W
Irvine, US
100 5 Jenner
Nashville, US
20 618 Grassmere Park
Tampa, US
228 10002 Princess Palm Ave

NeoGenomics Laboratories Financials and Metrics

NeoGenomics Laboratories Financials

NeoGenomics Laboratories's revenue was reported to be $244.1 m in FY, 2016
USD

Revenue (Q2, 2017)

66.1 m

Gross profit (Q2, 2017)

31.2 m

Gross profit margin (Q2, 2017), %

47%

Net income (Q2, 2017)

(43 k)

EBIT (Q2, 2017)

1.3 m

Market capitalization (11-Dec-2017)

226.9 m

Cash (30-Jun-2017)

10.9 m
NeoGenomics Laboratories's current market capitalization is $226.9 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

66.5 m87.1 m99.8 m244.1 m

Revenue growth, %

31%15%145%

Cost of goods sold

34.7 m46.4 m56 m133.7 m

Gross profit

31.7 m40.7 m43.8 m110.4 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

16.9 m18.2 m20.7 m23.2 m23 m24.4 m25.1 m59.7 m63.1 m60.8 m61.7 m66.1 m

Cost of goods sold

8.7 m9.5 m10.4 m12.9 m13.5 m13.6 m14 m32.5 m34.5 m33.4 m34.5 m34.9 m

Gross profit

8.2 m8.7 m10.2 m10.3 m9.5 m10.8 m11.2 m27.2 m28.6 m27.3 m27.2 m31.2 m

Gross profit Margin, %

48%48%50%44%41%44%44%46%45%45%44%47%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

4.8 m33.7 m23.4 m12.5 m

Accounts Receivable

18.7 m20.5 m48.9 m55.5 m

Inventories

2.3 m2.6 m5.1 m6.3 m

Current Assets

27.5 m58.7 m99 m78.8 m
USDQ3, 2013Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

4.9 m33 m34 m19.3 m21.8 m28.9 m11 m10.9 m

Accounts Receivable

15.7 m21.1 m21.6 m50.1 m53.5 m50.2 m61.7 m61.8 m

Inventories

2.1 m3.4 m3 m5.3 m5.5 m6 m6 m5.5 m

Current Assets

23.8 m59.6 m60.9 m81.2 m87.5 m92.6 m84.6 m83.4 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2 m1.1 m(2.5 m)(5.7 m)

Depreciation and Amortization

4.2 m7.1 m23.2 m

Inventories

(229 k)(896 k)(1.1 m)

Cash From Operating Activities

2.2 m9.5 m6.4 m21.5 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

1.2 m102 k376 k85 k(761 k)(937 k)(1.1 m)155 k568 k500 k(654 k)(697 k)

Depreciation and Amortization

3.1 m1.2 m2.4 m3.9 m5.6 m11 m17 m5.7 m11.4 m

Inventories

21 k(800 k)(351 k)(437 k)(844 k)

Accounts Payable

(1.1 m)(41 k)2 k
USDY, 2017

Revenue/Employee

70.5 k

Financial Leverage

2 x
Show all financial metrics

NeoGenomics Laboratories Market Value History

NeoGenomics Laboratories's Web-traffic and Trends

NeoGenomics Laboratories Online and Social Media Presence

NeoGenomics Laboratories Company Life and Culture

You may also be interested in